RCM
ZURAW

Radcliffe Capital Management’s Zura Bio Limited Warrants ZURAW Stock Holding History

Radcliffe Capital Management’s Portfolio ZURAW Stock Details ZURAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-64,271
Closed -$16.4K – 600
2023
Q1 		$16.4K Sell
64,271
-60,729
-49% -$17.3K ﹤0.01% 456
2022
Q4 		$1.28M Hold
125,000
– – 0.04% 604
2022
Q3 		$1.26M Hold
125,000
– – 0.03% 831
2022
Q2 		$1.24M Hold
125,000
– – 0.03% 882
2022
Q1 		$1.24M Hold
125,000
– – 0.03% 871
2021
Q4 		$1.23M Hold
125,000
– – 0.03% 756
2021
Q3 		$1.23M Buy
+125,000
New +$72.9K 0.04% 644

Other funds holding ZURAW

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Radcliffe Capital Management's ZURAW Position: Q2 2023 in Review

Radcliffe Capital Management sold out of Zura Bio Limited Warrants (ZURAW) in Q2 2023, closing a stake of 64,271 shares — an estimated $16.4K sold.

Radcliffe Capital Management first reported a position in ZURAW in Q3 2021 and held it in 7 quarters. The position peaked at $1.28M in Q4 2022. 13 funds tracked by Wall St. Rank hold ZURAW as of Q2 2023.

  • Radcliffe Capital Management reported no remaining Zura Bio Limited Warrants position as of Q2 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 64,271 Zura Bio Limited Warrants shares in Q2 2023, an estimated $16.4K.
  • Radcliffe Capital Management first reported a position in Zura Bio Limited Warrants in Q3 2021 and held it in 7 quarters.
  • Radcliffe Capital Management's Zura Bio Limited Warrants position peaked at $1.28M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q2 2023.

Based on Radcliffe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.